TrialClinical lymphoma, myeloma & leukemia2013

Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome.

Hady Ghanem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.